These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35813183)

  • 21. Exploring the benefits of a stroke telemedicine programme: An organisational and societal perspective.
    Bagot KL; Bladin CF; Vu M; Kim J; Hand PJ; Campbell B; Walker A; Donnan GA; Dewey HM; Cadilhac DA;
    J Telemed Telecare; 2016 Dec; 22(8):489-494. PubMed ID: 27799453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public Health and Cost Benefits of Successful Reperfusion After Thrombectomy for Stroke.
    Kunz WG; Almekhlafi MA; Menon BK; Saver JL; Hunink MG; Dippel DWJ; Majoie CBLM; Liebeskind DS; Jovin TG; Davalos A; Bracard S; Guillemin F; Campbell BCV; Mitchell PJ; White P; Muir KW; Brown S; Demchuk AM; Hill MD; Goyal M;
    Stroke; 2020 Mar; 51(3):899-907. PubMed ID: 31964289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran.
    Amiri A; Goudarzi R; Amiresmaili M; Iranmanesh F
    J Med Econ; 2018 Mar; 21(3):282-287. PubMed ID: 29105528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.
    Ehlers L; Müskens WM; Jensen LG; Kjølby M; Andersen G
    CNS Drugs; 2008; 22(1):73-81. PubMed ID: 18072816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prospective Economic Evaluation of Rapid Endovascular Therapy for Acute Ischemic Stroke.
    Sevick LK; Demchuk AM; Shuaib A; Smith EE; Rempel JL; Butcher K; Menon BK; Jeerakathil T; Kamal N; Thornton J; Williams D; Poppe AY; Roy D; Goyal M; Hill MD; Clement F;
    Can J Neurol Sci; 2021 Nov; 48(6):791-798. PubMed ID: 33431075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost effectiveness analysis of the East of England stroke telemedicine service.
    Afolabi O; Parsekar K; Sibson L; Patel A; Fordham R
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):106939. PubMed ID: 36689794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Societal value of stem cell therapy in stroke--a modeling study.
    Svensson J; Ghatnekar O; Lindgren A; Lindvall O; Norrving B; Persson U; Kokaia Z
    Cerebrovasc Dis; 2012; 33(6):532-9. PubMed ID: 22571941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving acute stroke care in regional hospitals: clinical evaluation of the Victorian Stroke Telemedicine program.
    Bladin CF; Kim J; Bagot KL; Vu M; Moloczij N; Denisenko S; Price C; Pompeani N; Arthurson L; Hair C; Rabl J; O'Shea M; Groot P; Bolitho L; Campbell BC; Dewey HM; Donnan GA; Cadilhac DA
    Med J Aust; 2020 May; 212(8):371-377. PubMed ID: 32255520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.
    Padwal RS; So H; Wood PW; Mcalister FA; Siddiqui M; Norris CM; Jeerakathil T; Stone J; Valaire S; Mann B; Boulanger P; Klarenbach SW
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):159-168. PubMed ID: 30570200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness Analysis of a Mobile Ear Screening and Surveillance Service versus an Outreach Screening, Surveillance and Surgical Service for Indigenous Children in Australia.
    Nguyen KH; Smith AC; Armfield NR; Bensink M; Scuffham PA
    PLoS One; 2015; 10(9):e0138369. PubMed ID: 26406592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
    Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
    Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the impact of a long-term horizon and multiple treatment episodes on estimates of the cost-effectiveness of alcohol treatment in the United States.
    Barbosa C; Dowd WN; Karriker-Jaffe KJ; Zarkin G
    Alcohol Clin Exp Res (Hoboken); 2023 Nov; 47(11):2121-2137. PubMed ID: 38226759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endovascular thrombectomy in patients with large core ischemic stroke: a cost-effectiveness analysis from the SELECT study.
    Sarraj A; Pizzo E; Lobotesis K; Grotta JC; Hassan AE; Abraham MG; Blackburn S; Day AL; Dannenbaum MJ; Hicks W; Vora NA; Budzik RF; Sharrief AZ; Martin-Schild S; Sitton CW; Pujara DK; Lansberg MG; Gupta R; Albers GW; Kunz WG;
    J Neurointerv Surg; 2021 Oct; 13(10):875-882. PubMed ID: 33188155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time Gain Needed for In-Ambulance Telemedicine: Cost-Utility Model.
    Valenzuela Espinoza A; Devos S; van Hooff RJ; Fobelets M; Dupont A; Moens M; Hubloue I; Lauwaert D; Cornu P; Brouns R; Putman K
    JMIR Mhealth Uhealth; 2017 Nov; 5(11):e175. PubMed ID: 29175808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of stent-retriever thrombectomy in large vessel occlusion strokes of the anterior circulation: Analysis from the French societal perspective.
    Barral M; Armoiry X; Boudour S; Aulagner G; Schott AM; Turjman F; Gory B; Viprey M
    Rev Neurol (Paris); 2020 Mar; 176(3):180-188. PubMed ID: 31526554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.
    Magnuson EA; Chinnakondepalli K; Vilain K; Kearon C; Julian JA; Kahn SR; Goldhaber SZ; Jaff MR; Kindzelski AL; Herman K; Brady PS; Sharma K; Black CM; Vedantham S; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2019 Oct; 12(10):e005659. PubMed ID: 31592728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK.
    Lobotesis K; Veltkamp R; Carpenter IH; Claxton LM; Saver JL; Hodgson R
    J Med Econ; 2016 Aug; 19(8):785-94. PubMed ID: 27046347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.